Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]
*Sign up for news summaries and alerts from 340B Report